|
2024
|
Invention
|
Pyridine derivatives.
The invention relates to a compound of formula (I)
The invention relates... |
|
|
Invention
|
Process for the preparation of [ru(oac)2(ligand)] catalysts.
The invention comprises a process f... |
|
|
Invention
|
Method of verifying a program code of a synthesis computer program.
A method of verifying a prog... |
|
|
Invention
|
Pyrazole derivatives as sting agonists.
The present invention provides novel compounds having th... |
|
|
Invention
|
Synthesis of quinazoline compounds.
Provided herein are methods of synthesizing quinazoline comp... |
|
|
Invention
|
Spiro-oxazolones.
The present invention provides spiro-oxazolones, which act as V1a receptor mod... |
|
|
Invention
|
Method for screening a biological fluid sample for an analyte associated with proteinopathy using... |
|
|
Invention
|
Machine learning enabled estimation of differences between protein sequences. A method may includ... |
|
|
Invention
|
Drug combinations screening. Methods of screening drug combinations are described. The methods co... |
|
|
Invention
|
Process for manufacturing baloxavir marboxil. The invention relates to a novel process for making... |
|
|
Invention
|
Folr1 protease-activatable t cell bispecific antibodies.
The present invention generally relates... |
|
|
Invention
|
End-to-end integrated federated research platform. A federated analytics (FA)/federated learning ... |
|
|
Invention
|
Peptide biomarker. The present invention relates to a splice variant of an ICA1 protein that acts... |
|
|
Invention
|
New heterocyclic compounds. The invention provides new heterocyclic compounds having the general ... |
|
|
Invention
|
Antibody that binds to c3bbb. The present invention relates to anti-C3bBb antibodies and methods ... |
|
|
Invention
|
Method for decelerating the decay-dissociation of c3bbb complex. The present invention relates to... |
|
|
Invention
|
Macrocycles for the treatment of autoimmune disease. The application relates to compounds of form... |
|
|
Invention
|
Chimeric receptors.
The present invention generally relates to chimeric receptors comprising an ... |
|
|
Invention
|
Methods for producing molecules. Methods are disclosed for producing a molecule comprising a poly... |
|
|
Invention
|
Forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making.
Th... |
|
|
Invention
|
Antibody formulation. This invention relates to a pharmaceutical formulation of an alpha synuclei... |
|
|
Invention
|
Machine learning models for cell line selection.
Methods for facilitating selection of cell line... |
|
|
Invention
|
Machine learning models for cell line selection. Methods for facilitating selection of cell lines... |
|
|
Invention
|
Gene biomarkers for mammalian cell pool productivity prediction and screening. Methods for select... |
|
|
Invention
|
New prop-2-ynamide derivatives. 133 are as defined in the description and in the claims. The comp... |
|
|
Invention
|
Novel methods for preparing semi-solid compositions and uses thereof. The present application dis... |
|
|
Invention
|
Inhibitors of the nlrp3 inflammasome. xyy are as described herein, composition including the comp... |
|
|
Invention
|
Container integrity testing system and method. A CCI testing system (1) to test closure integrity... |
|
|
Invention
|
Container intergity testing method and system. A CCI testing method to test physical container cl... |
|
|
Invention
|
Treatment of non small cell lung cancer with alectinib. The present invention relates to a method... |
|
|
Invention
|
Method for the generation of single stranded dna. The present invention relates to a method for t... |
|
|
Invention
|
Pyrazole derivatives as sarm1 inhibitors useful for the treatment of neurodegenerative disorders.... |
|
|
Invention
|
Protease activatable fc domain binding molecules. The present invention generally relates to nove... |
|
|
Invention
|
Process for manufacturing macrocyclic peptides.
The invention provides a novel process for manuf... |
|
|
Invention
|
Pharmaceutical formulation comprising a coated tablet. The invention relates to pharmaceutical fo... |
|
|
Invention
|
Liver cirrhosis detection in digital images.
The present invention relates to systems and method... |
|
|
Invention
|
Process for the preparation of 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyr... |
|
|
Invention
|
Process for preparing btk inhibitors.
Methods for preparing the Bruton's Tyrosine Kinase (“BTK”)... |
|
|
Invention
|
Her2-targeting antigen binding molecules comprising 4-1bbl.
The invention relates to Her2 target... |
|
|
Invention
|
Agonistic cd28 antigen binding molecules targeting her2.
The present invention relates to Her2-t... |
|
|
Invention
|
Antibodies binding to cd3.
The present invention generally relates to antibodies that bind to CD... |
|
|
Invention
|
Process for synthesis of quinazoline compounds.
Provided herein are methods to synthesize compou... |
|
|
Invention
|
Immunoconjugates.
The present invention generally relates to immunoconjugates, particularly immu... |
|
|
Invention
|
Antigen binding molecules comprising a tnf family ligand trimer.
The invention relates to novel ... |
|
|
Invention
|
Quantification of low amounts of antibody side-products.
The current invention is directed to a ... |
|
|
Invention
|
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma.
Provided he... |
|
|
Invention
|
Combination therapy of anti-tyrp1/anti-cd3 bispecific antibodies and tyrp1-specific antibodies.
... |
|
|
G/S
|
Antibiotic Preparation |
|
2023
|
Invention
|
Oligonucleotides for inducing paternal ube3a expression.
The present invention relates to oligon... |
|
|
Invention
|
Heterocyclic compounds.
The invention provides new heterocyclic compounds having the general for... |
|
2022
|
Invention
|
Novel heteroaryl compounds.
The invention provides new heteroaromatic compounds having the gener... |
|
|
G/S
|
Online-information services, namely, providing on-line information about accessing computer netwo... |
|
2019
|
G/S
|
Medical and scientific research in the field of diabetes; Consultation pertaining to pharmacology... |
|
2017
|
G/S
|
laboratory instruments, namely, clinical chemistry analyzers and immunochemistry analyzers for th... |
|
|
G/S
|
a full line of in vitro diagnostic agent, namely, reagents, control solutions for calibrating and... |
|
|
G/S
|
medical diagnostic test strips for determining the level of glucose in blood for medical and clin... |
|
|
G/S
|
blood glucose monitors for medical purposes, lancet devices, lancets; insulin delivery devices an... |
|
2008
|
G/S
|
full line of pharmaceutical preparations |
|
|
G/S
|
pharmaceutical antiviral preparation |
|
2000
|
G/S
|
[ Chemical products, namely, diagnostic preparations for scientific or medical research use; cont... |
|
1999
|
G/S
|
providing information about a pharmaceutical company and its products and services via a web site... |
|
1997
|
G/S
|
pharmaceutical preparation, namely, an anticancer drug |
|
1994
|
G/S
|
pharmaceutical preparation; namely, an antiviral |
|
1993
|
G/S
|
pharmaceutical preparation, namely an immunosuppressive agent |
|
1985
|
G/S
|
COMPUTERS AND ELECTRONIC LABORATORY TESTING APPARATUS USED FOR ANALYSIS OF BIOLOGICAL FLUIDS, PHA... |
|
1984
|
G/S
|
Clinical Laboratory Services |
|
1977
|
G/S
|
[ PROVIDING COMPUTER SCORED PSYCHIATRIC AND PSYCHOLOGICAL TESTING SERVICES; ] PROVIDING PHARMACEU... |
|
|
G/S
|
MEDICAL BOOKLETS AND PAMPHLETS |
|
|
G/S
|
PHARMACEUTICAL PREPARATIONS FOR HUMAN [AND VETERINARY] USE |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS[; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE C... |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS [ ; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE... |
|
1949
|
G/S
|
[ AGENTS USED IN ALLERGY, ANALGESICS, ANALEPTICS, ] ANTI-INFECTIVES [, ANTISPASMODICS ANESTHETIC... |
|
1897
|
G/S
|
CHEMICAL PRODUCTS FOR USE IN MEDICINE AND PHARMACY [ , DISINFECTANTS, AND PERFUMES ] |
